2020 - Lifecycle Management of Analytical Methods and Procedures - according to new FDA and USP guidelines
Date2020-10-08 - 2020-10-09
Deadline2020-09-28
VenueVirtual Seminar, USA - United States
KeywordsUSP General Chapter 1058; Analytical life cycle; Usp analytical method
Topics/Call fo Papers
Learn about the regulatory background and recommendations for managing the lifecycle of analytical methods and procedures
Understand current and future industry trends: the concept of lifecycle management of analytical methods, recent USP General Chapter 1210 (Statistical Tools for Procedure Validation), and Quality by Design (QbD) principles for method development and validation
Learn how to plan, execute and document design, development and validation of methods developed in-house
Understand the principles of lifecycle management for compendial procedures and for managing method transfer
Be able to develop a strategy for analytical procedure lifecycle management
Understand risk management strategies throughout the procedure lifecycle
Understand the concept of measurement uncertainty
Be able to justify and document decisions about type and extend of revalidation after method changes
Be able to define and demonstrate FDA, EU, USP and ICH compliance to auditors and inspectors
Be able to develop inspection-ready documentation during on-going routine operation
Understand what questions will be asked during audits and inspections and how to answer them
Understand current and future industry trends: the concept of lifecycle management of analytical methods, recent USP General Chapter 1210 (Statistical Tools for Procedure Validation), and Quality by Design (QbD) principles for method development and validation
Learn how to plan, execute and document design, development and validation of methods developed in-house
Understand the principles of lifecycle management for compendial procedures and for managing method transfer
Be able to develop a strategy for analytical procedure lifecycle management
Understand risk management strategies throughout the procedure lifecycle
Understand the concept of measurement uncertainty
Be able to justify and document decisions about type and extend of revalidation after method changes
Be able to define and demonstrate FDA, EU, USP and ICH compliance to auditors and inspectors
Be able to develop inspection-ready documentation during on-going routine operation
Understand what questions will be asked during audits and inspections and how to answer them
Other CFPs
- REACH and RoHS Compliance: Gain a Deeper Understanding
- Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs)
- Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs)
- The Risk-Based Approach to Pharmacovigilance Audits - A Practical Approach to Design and Implementation
- Foundations of Change Management for HR Professionals
Last modified: 2020-09-22 21:19:33